BioLine RX Stock

BioLine RX Shares Outstanding

The The number of shares of BioLine RX (BLRX.TA) as of Sep 2, 2026 is 1.20 B. In the previous year, The number of shares was 1.20 B — a change of 0.00% (lower).

Shares Outstanding

1.20 B

YoY

0.00%

Last updated:

In 2026, BioLine RX had 1.20 B outstanding stocks, a 0.00% change from the 1.20 B stocks in the previous year.

The BioLine RX Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2017
1.20 B USD
Jan 1, 2018
1.20 B USD
Jan 1, 2019
1.20 B USD
Jan 1, 2020
1.20 B USD
Jan 1, 2021
1.20 B USD
Jan 1, 2022
1.20 B USD
Jan 1, 2023
1.20 B USD
Jan 1, 2024
1.20 B USD
The BioLine RX Shares Outstanding history
YEARShares OutstandingYoY
1.20 B0.00%
1.20 B0.00%
1.20 B0.00%
1.20 B0.00%
1.20 B0.00%
1.20 B0.00%
1.20 B0.00%
1.20 B0.00%
1.20 B0.00%
1.20 B0.00%
1.20 B+5.33 B%
22.49+32.76%
16.94+37.06%
12.36-0.72%
12.45+27.56%
9.76+52.98%
6.38+18.15%
5.40-12.05%
6.140.00%
6.14—
Access this data via the Eulerpool API
Get Free API Key

BioLine RX Number of shares

BioLine RX shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
89.97 M Stocks
Jan 1, 2018
108.60 M Stocks
Jan 1, 2019
146.41 M Stocks
Jan 1, 2020
252.84 M Stocks
Jan 1, 2021
662.93 M Stocks
Jan 1, 2022
773.96 M Stocks
Jan 1, 2023
963.37 M Stocks
Jan 1, 2024
1.20 B Stocks

BioLine RX Stock analysis

What does BioLine RX do? BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe. BioLine RX is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating BioLine RX's Shares Outstanding

BioLine RX's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in BioLine RX’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding BioLine RX’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in BioLine RX’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about BioLine RX stock

The number of shares of BioLine RX is 1.20 B in 2026.

The number of shares of BioLine RX changed from 1.20 B to 1.20 B, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares BioLine RX since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API
Get Free API Key

Other — BioLine RX

Shares OutstandingSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — BioLine RX